Pacific Shuanglin Bio-pharmacy Co., LTD Stock Forecast for 2023 - 2025 - 2030
Updated on 04/30/2024
Pacific Shuanglin Bio-pharmacy Co., LTD Stock Forecast and Price Target
The average price target for Pacific Shuanglin Bio-pharmacy Co., LTD's stock of ¥30.00 recently provided by leading analysts would represent a 2.42% upside from its last closing price if reached. This potential increase is based on a high estimate of ¥30.00 and a low estimate of ¥30.00. If you are not interested in 000403 stock, you may still be interested in its competitors and their current standings.
2.42% Upside
Pacific Shuanglin Bio-pharmacy Co., LTD Fair Value Forecast for 2023 - 2025 - 2030
In the last two years, Pacific Shuanglin Bio-pharmacy Co., LTD's Price has fallen from ¥33.22 to ¥0.00 – a 100.00% decrease. For next year, analysts predict Fair Value of ¥85.68, which would mean an increase of 100.00%. Over the next seven years, experts predict that Pacific Shuanglin Bio-pharmacy Co., LTD's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 300122 Stock Forecast | Chongqing Zhifei Biological Pr... | Buy |
16
|
¥35.10 | Buy/Sell | ¥72.72 | 85.19% |
| 1801 Stock Forecast | Innovent Biologics | Buy |
6
|
HK$38.25 | Buy/Sell | HK$50.72 | 33.33% |
| 002252 Stock Forecast | Shanghai RAAS Blood Products | Buy |
18
|
¥7.18 | Buy/Sell | ¥9.08 | -2.51% |
| 600161 Stock Forecast | Beijing Tiantan Biological Pro... | Outperform |
18
|
¥28.77 | Buy/Sell | ¥31.28 | 10.74% |
| 000661 Stock Forecast | Changchun High-Tech Industries... | Buy |
18
|
¥113.06 | Buy/Sell | ¥211.29 | 72.78% |
Pacific Shuanglin Bio-pharmacy Co., LTD Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Pacific Shuanglin Bio-pharmacy Co., LTD's Revenue has grown by 121.80%, rising from ¥1.05B to ¥2.33B. According to 0 prominent analysts, Pacific Shuanglin Bio-pharmacy Co., LTD's Revenue will fall by 20.50% in the next year, reaching ¥1.85B. By 2030, professionals believe that Pacific Shuanglin Bio-pharmacy Co., LTD's Revenue will decrease by 12.30%, reaching ¥2.04B – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 002007 Stock Forecast | Hualan Biological Engineering | Outperform |
18
|
¥19.47 | Buy/Sell | ¥25.89 | 34.05% |
| NasdaqGS:CBPO Stock Forecast | China Biologic Products Holdin... | - |
16
|
$118.41 | Buy/Sell | $103.00 | -100.00% |
| 9926 Stock Forecast | Akeso | Buy |
4
|
HK$48.15 | Buy/Sell | HK$49.90 | 14.50% |
.jpg)
Pacific Shuanglin Bio-pharmacy Co., LTD Dividend per Share Forecast for 2023 - 2025 - 2030
In the last year, Pacific Shuanglin Bio-pharmacy Co., LTD's Dividend per Share has grown by 33.33%, rising from ¥0.06 to ¥0.08. For next year, analysts predict Dividend per Share of ¥0.09, which would mean an increase of 12.50%. Over the next seven years, experts predict that Pacific Shuanglin Bio-pharmacy Co., LTD's Dividend per Share will grow at a rate of 18.02%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 688278 Stock Forecast | Xiamen Amoytop Biotech | Buy |
15
|
¥60.51 | Buy/Sell | ¥83.00 | 42.29% |
| 1877 Stock Forecast | Shanghai Junshi Biosciences | Outperform |
7
|
HK$11.76 | Buy/Sell | HK$31.29 | 61.73% |
| 300142 Stock Forecast | Walvax Biotechnology | Hold |
15
|
¥14.71 | Buy/Sell | ¥22.00 | 35.96% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 300601 Stock Forecast | Shenzhen Kangtai Biological Pr... | Buy |
16
|
¥20.20 | Buy/Sell | ¥36.61 | 73.27% |
| 300676 Stock Forecast | BGI Genomics | - |
17
|
¥41.13 | Buy/Sell | ¥0.00 | -100.00% |
| 300009 Stock Forecast | Anhui Anke Biotechnology (Grou... | Buy |
18
|
¥10.22 | Buy/Sell | ¥19.54 | 91.19% |
Pacific Shuanglin Bio-pharmacy Co., LTD EBITDA Forecast for 2023 - 2025 - 2030
Pacific Shuanglin Bio-pharmacy Co., LTD's EBITDA has grown In the last three years, rising from ¥273.96M to ¥810.97M – a growth of 196.02%. In the next year, analysts believe that EBITDA will reach ¥871.00M – an increase of 7.40%. For the next seven years, experts predict that Pacific Shuanglin Bio-pharmacy Co., LTD's EBITDA will grow at a rate of 11.93%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 300294 Stock Forecast | China Resources Boya Bio-pharm... | Buy |
16
|
¥31.46 | Buy/Sell | ¥35.07 | 9.15% |
| 002030 Stock Forecast | Daan Gene | - |
17
|
¥8.37 | Buy/Sell | ¥0.00 | -100.00% |
| 1530 Stock Forecast | 3SBio | Outperform |
14
|
HK$6.28 | Buy/Sell | HK$7.92 | 10.35% |
Pacific Shuanglin Bio-pharmacy Co., LTD EBIT Forecast for 2023 - 2025 - 2030
Pacific Shuanglin Bio-pharmacy Co., LTD's EBIT has seen impressive growth In the last three years, rising from ¥226.59M to ¥695.14M – a growth of 206.78%. In the next year, analysts believe that EBIT will reach ¥821.00M – an increase of 18.11%. For the next seven years, the forecast is for EBIT to grow by 19.81%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 688266 Stock Forecast | Suzhou Zelgen Biopharmaceutica... | Buy |
8
|
¥55.10 | Buy/Sell | ¥58.00 | 16.15% |
| 300026 Stock Forecast | Tianjin Chase Sun Pharmaceutic... | Buy |
14
|
¥3.86 | Buy/Sell | ¥7.66 | 3.63% |
| 300406 Stock Forecast | Beijing Strong Biotechnologies... | Buy |
18
|
¥18.70 | Buy/Sell | ¥0.00 | -100.00% |
Pacific Shuanglin Bio-pharmacy Co., LTD EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last two years, Pacific Shuanglin Bio-pharmacy Co., LTD's EPS has fallen from ¥0.38 to ¥0.00 – a 100.00% decrease. For next year, analysts predict EPS of ¥0.98, which would mean an increase of 100.00%. Over the next seven years, experts predict that Pacific Shuanglin Bio-pharmacy Co., LTD's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 000990 Stock Forecast | Chengzhi | Buy |
15
|
¥7.73 | Buy/Sell | ¥0.00 | -100.00% |
| ZLAB Stock Forecast | Zai Lab | Buy |
6
|
$15.80 | Buy/Sell | $66.67 | 282.91% |
| 600201 Stock Forecast | Jinyu Bio-technology | Outperform |
18
|
¥9.14 | Buy/Sell | ¥10.29 | 9.41% |
Site Navigation
.jpg)